Who Would Be the Best FDA Commissioner for Biotech Investors?

Robert Califf has been nominated as the next Food and Drug Administration (FDA) Commissioner, despite some expectations that the choice would be the current acting commissioner Janet Woodcock. Both had seemed well qualified for the position.

In this Motley Fool Live video recorded on Nov. 15, Motley Fool contributors Keith Speights and Brian Orelli discuss Califf's previous experience working at the FDA and with pharmaceutical companies. The other possible nominee, Woodcock, greatly emphasized making the FDA's expectations clear for biotech companies trying to get their drugs approved, which could have helped companies in the industries.

Continue reading

Source Fool.com